Biogen agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion, expanding its portfolio in immunology and rare-disease medicines.
Source link
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
Date:
More like thisRelated
Crews battling two wildfires near Clines Corner
Fire crews are currently battling two wildfires near I-40...
Will Anyone Buy This Cheap EV Truck With Hand-Crank Windows and No Radio?
Slate Auto’s all-electric truck, priced in the mid-$20,000s, aims...
North Korea’s Kim claims progress on nuclear-armed navy as new warship is placed into service
SEOUL, South Korea -- North Korea has commissioned a...